Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
Trial details
- Registry ID
- NCT03520686
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerNCT03520686 | IBRX | Phase 3 | Terminated | 2025-10-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |